文献速递呼吸衰竭与机械通气儿科与产科急症

鼻持续气道正压通气与加温湿化高流量鼻导管对早产儿呼吸窘迫综合征喂养不耐受的影响:ENTARES随机临床试验

Effect of Nasal Continuous Positive Airway Pressure vs Heated Humidified High-Flow Nasal Cannula on Feeding Intolerance in Preterm Infants With Respiratory Distress Syndrome: The ENTARES Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2023-07-03
一句话结论在25–29周呼吸窘迫综合征早产儿中,NCPAP与HHHFNC达到全肠内喂养时间相似(均为14天),但NCPAP首次更换无创呼吸支持时SpO2-FIO2比值更高、无效率更低。

这项多中心随机临床试验在意大利13个新生儿重症监护病房纳入247例胎龄25–29周、可肠内喂养且在无创呼吸支持上稳定至少48小时的早产儿,随机分为NCPAP组(n=122)与HHHFNC组(n=125)。主要终点为达到全肠内喂养(150 mL/kg/天)的时间,两组均为14天(NCPAP组95%CI 11–15天;HHHFNC组95%CI 12–18天),营养结局无差异。首次更换无创呼吸支持时,NCPAP组SpO2-FIO2比值更高(中位4.6 vs 3.7,P<.001),无效率更低(1例[4.8%] vs 17例[73.9%],P<.001)。作者认为临床医生可基于呼吸有效性和患者依从性在两种技术间选择和切换,不影响喂养不耐受。

要点

  • 25–29周呼吸窘迫综合征早产儿中,NCPAP组与HHHFNC组达到全肠内喂养(150 mL/kg/天)的中位时间均为14天(NCPAP组95%CI 11–15天;HHHFNC组95%CI 12–18天),无差异。
  • 首次更换无创呼吸支持时,NCPAP组SpO2-FIO2比值中位4.6(IQR 4.1–4.7)高于HHHFNC组3.7(IQR 3.2–4.0),P<.001。
  • 首次更换无创呼吸支持时,NCPAP组无效率4.8%(1例)低于HHHFNC组73.9%(17例),P<.001。
  • 胎龄小于28周亚组中,两组达到全肠内喂养时间结果相似。
  • 作者认为临床医生可基于呼吸有效性和患者依从性选择并切换两种无创呼吸支持技术,不影响喂养不耐受。

适用人群与场景

  • 胎龄25–29周、适合肠内喂养、在无创呼吸支持上医学稳定至少48小时的早产儿,于生后第一周内纳入。
  • 意大利13个新生儿重症监护病房,2018年11月1日至2021年6月30日出生。

诊断标准与关键阈值

  • 全肠内喂养(FEF)定义为肠内摄入量达150 mL/kg/天。

研究设计与关键结果

  • 多中心随机临床试验,纳入247例早产儿(中位[IQR]胎龄28[27–29]周;女婴130例[52.6%]),随机分为NCPAP组(n=122)与HHHFNC组(n=125),按意向性治疗分析。
  • 主要终点达到全肠内喂养的中位时间:NCPAP组14天(95%CI 11–15天)vs HHHFNC组14天(95%CI 12–18天),两组主要与次要营养结局均无差异。
  • 胎龄小于28周亚组中达到全肠内喂养时间结果相似。
  • 首次更换无创呼吸支持时,NCPAP组SpO2-FIO2比值中位4.6(IQR 4.1–4.7)高于HHHFNC组3.7(IQR 3.2–4.0),P<.001。
  • 首次更换无创呼吸支持时,NCPAP组无效率4.8%(1例)低于HHHFNC组73.9%(17例),P<.001。

证据类型、等级与局限

  • 证据类型:多中心随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管两种无创呼吸支持技术工作机制不同,对喂养不耐受的影响相似,临床医生可基于呼吸有效性和患者依从性在NCPAP与HHHFNC之间选择和切换,不影响喂养不耐受。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Respiratory distress syndrome and feeding intolerance are common conditions that are often associated with preterm infants. Showing similar efficacy, nasal continuous positive airway pressure (NCPAP) and heated humidified high-flow nasal cannula (HHHFNC) are the most widespread noninvasive respiratory support (NRS) in neonatal intensive care units, but their effect on feeding intolerance is unknown.

OBJECTIVE: To evaluate the effect of NCPAP vs HHHFNC on high-risk preterm infants with respiratory distress syndrome.

DESIGN, SETTING, AND PARTICIPANTS: This multicenter randomized clinical trial involved infants who were born in 1 of 13 neonatal intensive care units in Italy between November 1, 2018, and June 30, 2021. Preterm infants with a gestational age of 25 to 29 weeks, who were suitable for enteral feeding and who proved to be medically stable on NRS for at least 48 hours were enrolled in the study within the first week of life and randomized to receive either NCPAP or HHHFNC. Statistical analysis was performed according to the intention-to-treat approach.

INTERVENTION: NCPAP or HHHFNC.

MAIN OUTCOMES AND MEASURES: The primary outcome was the time to full enteral feeding (FEF), defined as an enteral intake of 150 mL/kg per day. Secondary outcomes were the median daily increment of enteral feeding, signs of feeding intolerance, effectiveness of the assigned NRS, peripheral oxygen saturation (SpO2)-fraction of inspired oxygen (FIO2) ratio at changes of NRS, and growth.

RESULTS: Two-hundred forty-seven infants (median [IQR] gestational age, 28 [27-29] weeks; 130 girls [52.6%]) were randomized to the NCPAP group (n = 122) or the HHHFNC group (n = 125). There were no differences in the primary and secondary nutritional outcomes between the 2 groups. The median time to reach FEF was 14 days (95% CI, 11-15 days) in the NCPAP group and 14 days (95% CI, 12-18 days) in the HHHFNC group, and similar results were observed in the subgroup of infants with less than 28 weeks' gestation. On the first NRS change, higher SpO2-FIO2 ratio (median [IQR], 4.6 [4.1-4.7] vs 3.7 [3.2-4.0]; P < .001) and lower rate of ineffectiveness (1 [4.8%] vs 17 [73.9%]; P < .001) were observed in the NCPAP vs HHHFNC group.

CONCLUSIONS AND RELEVANCE: This randomized clinical trial found that NCPAP and HHHFNC had similar effects on feeding intolerance, despite different working mechanisms. Clinicians may tailor respiratory care by selecting and switching between the 2 NRS techniques on the basis of respiratory effectiveness and patient compliance, without affecting feeding intolerance.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03548324.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Cresi F, Maggiora E, Lista G, et al. Effect of Nasal Continuous Positive Airway Pressure vs Heated Humidified High-Flow Nasal Cannula on Feeding Intolerance in Preterm Infants With Respiratory Distress Syndrome: The ENTARES Randomized Clinical Trial. JAMA Netw Open. 2023. PMID: 37436750. doi:10.1001/jamanetworkopen.2023.23052

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。